Targretin

Product manufactured by Bausch Health Us, Llc

Application Nr Approved Date Route Status External Links
NDA021055 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Targretin ® (Bexarotene) Capsules Are Indicated For The Treatment Of Cutaneous Manifestations Of Cutaneous T-Cell Lymphoma In Patients Who Are Refractory To At Least One Prior Systemic Therapy. Targretin (Bexarotene) Is A Retinoid Indicated For The Treatment Of Cutaneous Manifestations Of Cutaneous T-Cell Lymphoma In Patients Who Are Refractory To At Least One Prior Systemic Therapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bexarotene BEXAROTENE ZINC1539579

Comments